Literature DB >> 9804685

Pharmacophoric search and 3D-QSAR comparative molecular field analysis studies on agonists of melatonin sheep receptors.

C Marot1, P Chavatte, L Morin-Allory, M C Viaud, G Guillaumet, P Renard, D Lesieur, A Michel.   

Abstract

Conformational analysis was used to characterize the agonist pharmacophore for melatonin sheep brain receptor recognition and activation. The molecular geometry shared by all conformations of the selected active ligands was determined. Assuming that all the compounds interact at the same binding site at the receptor level, 2-iodomelatonin pharmacophoric conformation served as a template for the superimposition of 64 structurally heterogeneous agonists constituting the training set used to perform a three-dimensional quantitative structure-activity relationship study via the comparative molecular field analysis method. A statistically significant model was obtained for the totality of the compounds (n = 64, q2 = 0.62, N = 6, r2 = 0.96, s = 0.28, F = 249) with steric, electrostatic, and lipophilic relative contributions of 28%, 35%, and 37%, respectively. The predictive power of the proposed model was discerned by successfully testing the 78 agonist ligands constituting the test set. The model so obtained and validated brings important structural insights to aid the design of novel melatoninergic agonist ligands prior to their synthesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9804685     DOI: 10.1021/jm980026p

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

1.  New quinoxaline derivatives as potential MT₁ and MT₂ receptor ligands.

Authors:  Saioa Ancizu; Nerea Castrillo; Silvia Pérez-Silanes; Ignacio Aldana; Antonio Monge; Philippe Delagrange; Daniel-Henry Caignard; Silvia Galiano
Journal:  Molecules       Date:  2012-06-25       Impact factor: 4.411

2.  Novel conformationally constrained analogues of agomelatine as new melatoninergic ligands.

Authors:  Marouan Rami; Elodie Landagaray; Mohamed Ettaoussi; Koussayla Boukhalfa; Daniel-Henri Caignard; Philippe Delagrange; Pascal Berthelot; Saïd Yous
Journal:  Molecules       Date:  2012-12-24       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.